Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total	$ (12,733,250)	$ (5,678,841)	$ (24,625,038)	$ (7,863,870)
Other comprehensive loss:
Foreign currency translation adjustment	(2,014)	0	(2,014)	0
Comprehensive loss including noncontrolling interests	(12,735,264)	(5,678,841)	(24,627,052)	(7,863,870)
Comprehensive loss attributable to noncontrolling interests	13,419	0	13,419	0
Comprehensive loss attributable to Statera Biopharma, Inc.	$ (12,721,845)	$ (5,678,841)	$ (24,613,633)	$ (7,863,870)